Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.

Sin, Yooksil; Yoshimatsu, Yuki; Noguchi, Rei; Tsuchiya, Ryuto; Sei, Akane; Ono, Takuya; Toki, Shunichi; Kobayashi, Eisuke; Arakawa, Ayumu; Sugiyama, Masanaka; Yoshida, Akihiko; Kawai, Akira; Kondo, Tadashi

Sin, Yooksil; Yoshimatsu, Yuki; Noguchi, Rei; Tsuchiya, Ryuto; Sei, Akane; Ono, Takuya; Toki, Shunichi; Kobayashi, Eisuke; Arakawa, Ayumu; Sugiyama, Masanaka; Yoshida, Akihiko; Kawai, Akira; Kondo, Tadashi.

Afiliação

Sin Y; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yoshimatsu Y; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Noguchi R; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Tsuchiya R; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Sei A; Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Ono T; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Toki S; Division of Rare Cancer Research, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kobayashi E; Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Arakawa A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Sugiyama M; Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yoshida A; Department of Pediatric Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kawai A; Department of Diagnosis Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kondo T; Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Hum Cell ; 33(4): 1311-1320, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32715445

Assuntos

Técnicas de Cultura de Células/métodos; Rabdomiossarcoma Alveolar; Sarcoma Alveolar de Partes Moles; Antineoplásicos/farmacologia; Linhagem Celular Tumoral; Pré-Escolar; Desenvolvimento de Medicamentos; Ensaios de Seleção de Medicamentos Antitumorais; Proteína Forkhead Box O1/genética; Fusão Gênica; Humanos; Metástase Linfática; Masculino; Estadiamento de Neoplasias; Fator de Transcrição PAX7/genética; Rabdomiossarcoma Alveolar/genética; Rabdomiossarcoma Alveolar/patologia; Sarcoma Alveolar de Partes Moles/genética; Sarcoma Alveolar de Partes Moles/patologia

Palavras-chave

Alveolar rhabdomyosarcoma; Cell line; Chemotherapy; Drug response; Primary culture cells

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma Alveolar de Partes Moles / Rabdomiossarcoma Alveolar / Técnicas de Cultura de Células Tipo de estudo: Prognostic_studies Limite: Child, preschool / Humans / Male Idioma: En Revista: Hum Cell Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google